• Wion
  • /Sports
  • /Tennis - No decision on Jannik Sinner’s doping case before new year: WADA

Tennis - No decision on Jannik Sinner’s doping case before new year: WADA

Tennis - No decision on Jannik Sinner’s doping case before new year: WADA

Tennis - No decision on Jannik Sinner’s doping case before new year: WADA

Tennis star Jannik Sinner's doping case will not have a decision from the Court of Arbitration for Sport (CAS) before the end of the year, the World Anti-Doping Agency (WADA) told AFP.

"There will be nothing by the end of the year," WADA director general Olivier Niggli said in an interview with AFP.

ALSO READ:Ruben Amorim plays down Manchester City contact before joining rivals United

Add WION as a Preferred Source

The Italian world number one twice tested positive for traces of the banned substance clostebol in March but was exonerated and allowed to carry on playing.

An independent tribunal at the end of August, requested by the International Tennis Integrity Agency (ITIA) found that the Australian Open and US Open champion "bears no fault or negligence".

The ITIA accepted Sinner's explanation that the drug entered his system when his physiotherapist used a spray containing it to treat a cut, then provided massage and sports therapy to the player.

WADA have appealed the decision to clear the 23-year-old and are seeking a ban of up to two years.

"It was considered in the decision that there was no fault on the part of Sinner. Our position is that there is still a responsibility of the athlete in relation to his entourage," Niggli said. "So it is this legal point that will be debated (before CAS).

"We do not dispute the fact that it could have been a contamination. But we believe that the application of the rules does not correspond to the case law."

While the ITIA were criticised for having revealed late the positive tests of Sinner and of women's world number two Iga Swiatek, Niggli believes that "athletes must be protected".

Swiatek last month accepted a one-month suspension after testing positive for the heart medication trimetazidine (TMZ) in an out-of-competition sample in August 2024.

"Personally, I think that protecting an athlete's reputation should be our first concern," said Niggli. "We live in a world where social media is what it is and means that a reputation can go up in smoke in a very, very short time."

Disclaimer:This story has been published from a news agency feed with minimal edits to adhere to WION's style guide. The headline may have been changed to better reflect the content of the story or to make it more suitable for WION audience.

About the Author

Gautam Sodhi

Meet Gautam, a seasoned journalist with over eight years of experience in covering the world of sports. I am a self-proclaimed cricket fanatic, having a deep passion for the game a...Read More